Hôpital le Vinatier
Quick facts
Marketed products
- Cannabidiol oral oil · Neurology/Psychiatry
Cannabidiol modulates endocannabinoid signaling and multiple other pathways to produce anxiolytic, anti-inflammatory, and neuroprotective effects.
Phase 3 pipeline
- Placebo oral oil
Placebo oral oil produces no pharmacological effect, serving as an inert control in clinical trials.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: